Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yorie Ohata"'
Autor:
Hiroko Kurioka, Yumiko Iba, Yorie Ohata, Toshiko Toda, Tasuku Harada, Yukihiro Azuma, Ikuko Ota, Hiroshi Sunada, Hisashi Noma, Yusuke Endo, Yukiko Tagashira, Fuminori Taniguchi
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 45:168-175
AIMS Dydrogesterone is a retro-progesterone preparation widely used for over a half century. We sought to evaluate the efficacy and safety of dydrogesterone in Japanese women with dysmenorrhea. METHODS This study was conducted as an open-label, singl
Autor:
Fuminori, Taniguchi, Ikuko, Ota, Yumiko, Iba, Toshiko, Toda, Yukiko, Tagashira, Yorie, Ohata, Hiroko, Kurioka, Yusuke, Endo, Hiroshi, Sunada, Hisashi, Noma, Yukihiro, Azuma, Tasuku, Harada
Publikováno v:
The journal of obstetrics and gynaecology research. 45(1)
Dydrogesterone is a retro-progesterone preparation widely used for over a half century. We sought to evaluate the efficacy and safety of dydrogesterone in Japanese women with dysmenorrhea.This study was conducted as an open-label, single-arm, multice
Publikováno v:
JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY. 28:443-447
Publikováno v:
Fertility and Sterility. 90:994-999
Objective To determine whether serum interleukin (IL)-8 concentration can be measured in patients with ovarian endometrioma and whether this measurement is a useful tool in diagnosing this disease. Design A controlled clinical study and an in vitro s
Publikováno v:
MHR: Basic science of reproductive medicine. 7:665-670
We have investigated the possible roles of oncostatin M (OSM), which is a member of the interleukin-6 family of cytokines, in endometrial and endometriotic stromal cell growth. Endometrial and endometriotic stromal cells were collected from the uteru
Publikováno v:
Gynecologic and Obstetric Investigation. 50:186-188
The aim of our study was to determine the efficacy of postponing administration of human chorionic gonadotropin while continuing daily gonadotropin-releasing hormone agonist therapy (‘coasting’) to prevent the occurrence of severe ovarian hyperst